Navigation Links
Bio-Optronics bioPoint(TM) Patient ID Wristband System Enhancing Patient Safety
Date:4/27/2010

ROCHESTER, N.Y., April 27 /PRNewswire/ -- Bio-Optronics, Inc., a leader in healthcare workflow software, recently attended the American Organization of Nurse Executives (AONE) Annual Meeting in Indianapolis where it showcased its bioPoint™ Patient ID Wristband System. The customer-base for this safety-enhancing product is rapidly expanding and bioPoint™ will be exhibited again soon at the NPSF Patient Safety Congress in Orlando, Florida from May 18 to 19.

Currently, bioPoint™ is being used in over 50 VA hospitals and the wristband system sales rate more than tripled in 2008 to 2009. Its recognized and accepted enhanced safety system for patient protection ensures that the product's strong order rate continues to rise with sales both in VA and non-VA hospitals.

"It has the flexibility to interface to different back-end hospital information systems and different front-end printers and media," Bio-Optronics CEO and President Dan Kerpelman said. "We also offer flexible configurations, including client-server, client-server web and web, to meet different price and need points."

The bioPoint™ ID Wristband System provides a user-friendly interface with "WYSIWYG" design capabilities including a color-coding system that follows the American Hospital Association's recommendations for the standardization of wristband colors for safety tags. bioPoint™ can even incorporate a signature, fingerprint or other biometrics into the wristband.

With a fully customizable wristband, or with a choice of pre-populated designs, the color photographs, color-coded alerts, personalized logos and choice of barcodes, hospitals and clinics can identify patients more easily with a system that increases efficiency, reduces the potential for error and most importantly, improves patient safety.

To increase the safety of young patients and newborns especially, the Bio-Optronics bioPoint™ Wristband System allows for a link to be made between patients and other persons on the premises, including visitors, doctors and even other patients, for whom the product can seamlessly create badges using the same software, saving on time and resources.

About Bio-Optronics

Bio-Optronics develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction.

For 25 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service.

Bio-Optronics, +1 (585) 272-1960, http://www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
(Date:10/4/2017)...  According to the Centers for Disease Control and Prevention (CDC), ... Urgent Care is helping communities across Massachusetts , ... offering no-cost* flu shots through the end of the month. ... regulations. ... a flu shot is by the end of October, according to the ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association ... Featuring a collection of specialty vendors and unique items from across the nation, this ... health and wellness services offered by the VNA. The boutique will be open ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... 2017 , ... Planet Fitness, one of the largest and fastest growing franchisors ... a flagship location in Covington, LA at 401 N. U.S. Highway 190, in January ... Office Depot in the Holiday Square shopping center. Its location allows it to serve ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
Breaking Medicine News(10 mins):